This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Altria Group has been evolving with the changing industry dynamics. Given the rising health consciousness and stern government regulations to discourage smoking, this tobacco behemoth has been moving beyond traditional cigarettes and expanding in the smokeless category. We note that revenues from the oral product category have been steadily rising on the back of growing popularity for reduced risk products. In this respect, Altria is gaining from the sale of IQOS in United States, through its licensing deal with Phillip Morris. Further, Altria’s investment in Cronos Group highlights its focus on exploring the cannabis market.
Altria (MO) Falls More Steeply Than Broader Market: What Investors Need to Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $54.27, marking a -0.8% move from the previous day.
Time to Buy These Big Tobacco Stocks for Higher Highs?
by Shaun Pruitt
Big tobacco producers Altria Group (MO) and Philip Morris International (PM) have seen their stocks soar over +30% this year with both trading near 52-week highs.
Investors Heavily Search Altria Group, Inc. (MO): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching Altria (MO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Altria's Focus on Smoke-Free Products Aids Amid Soft Cigarette Volumes
by Zacks Equity Research
Altria is benefiting from its shift toward smoke-free products. This, along with pricing power, is aiding MO amid low cigarette volumes.
Altria (MO) Advances But Underperforms Market: Key Facts
by Zacks Equity Research
In the most recent trading session, Altria (MO) closed at $53.77, indicating a +0.77% shift from the previous trading day.
Altria (MO) Up 6.7% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Altria (MO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Altria Rallies 15% in 3 Months: Should You Buy, Hold or Sell MO Stock?
by Vrishali Bagree
Altria's push into smoke-free products presents promising growth opportunities, but the ongoing decline in its cigarette business poses challenges for MO stock.
Should VanEck Morningstar Wide Moat ETF (MOAT) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for MOAT
Zacks Investment Ideas feature highlights: Cardinal Health, Taiwan Semiconductor and Altria
by Zacks Equity Research
Zacks Investment Ideas feature highlights: Cardinal Health, Taiwan Semiconductor and Altria.
3 Consistent Dividend Growers to Buy for Passive Income: TSM, MO, CAH
by Derek Lewis
For those seeking companies with a consistent history of steady payouts, all three of these stocks fit the criteria. Who doesn't like payday?
Top Stock Reports for Toyota Motor, IBM & Stryker
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Toyota Motor Corporation (TM), International Business Machines Corporation (IBM) and Stryker Corporation (SYK), as well a micro-cap stock Fossil Group, Inc. (FOSL).
Altria Group, Inc. (MO) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Altria (MO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Should iShares Select Dividend ETF (DVY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DVY
Is iShares Select Dividend ETF (DVY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for DVY
Altria Group, Inc. (MO) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Altria (MO) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Is Invesco High Yield Equity Dividend Achievers ETF (PEY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for PEY
Company News for Aug 1, 2024
by Zacks Equity Research
Companies in The News Are: AMD, ANET, MA, MO
Altria's (MO) Q2 Earnings Lag Estimates, Cigarette Volumes Drop
by Zacks Equity Research
Altria's (MO) second-quarter 2024 results reflect strong pricing, while cigarette shipment volumes remain soft. Management narrows the adjusted EPS view for 2024.
Altria (MO) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Altria (MO) delivered earnings and revenue surprises of -2.96% and 2.77%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Is Franklin U.S. Low Volatility High Dividend Index ETF (LVHD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for LVHD
Altria's (MO) Q2 Earnings Coming Up: Buy, Sell or Hold Steady?
by Vrishali Bagree
Altria Group's (MO) second-quarter earnings are likely to reflect gains from the company's pricing power and smoke-free product strength amid soft cigarette volumes.
Is SPDR S&P Global Dividend ETF (WDIV) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for WDIV
Altria (MO) Hits 52-Week High: Time to Cash In or Hold Steady?
by Vrishali Bagree
Altria's (MO) strategic moves into smoke-free products offer growth potential, though the declining cigarette business raises concerns.
Why the Market Dipped But Altria (MO) Gained Today
by Zacks Equity Research
Altria (MO) concluded the recent trading session at $49.80, signifying a +0.77% move from its prior day's close.
Altria (MO) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Altria (MO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.